StocktoriaMUSTANG BIO, INC. MBIO
Nasdaq · XNAS · stock · Pharmaceutical Preparations
Chart by TradingView
2/9
Piotroski F — financial health
—
Altman Z″ — distress risk
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Operating income | -$2.4M | -$16.2M | -$49.3M | -$76.2M | -$66.7M |
| Net income | -$1.9M | -$15.8M | -$51.6M | -$77.5M | -$66.4M |
| Operating cash flow | -$5.3M | -$11.4M | -$49.5M | -$65.1M | -$53.7M |
| Free cash flow | — | -$11.4M | -$49.5M | -$67.8M | -$57.7M |
| Total assets | $17.6M | $9.3M | $17.7M | $92.4M | $125.2M |
| Total liabilities | $8.1M | $13.2M | $17.6M | $46.1M | $12.8M |
| Shareholders' equity | $9.5M | -$3.9M | $123,000 | $46.3M | $112.4M |
| Ratios | |||||
| Return on assets | -10.9% | -169.2% | -290.8% | -83.9% | -53.0% |
| Return on equity | -20.2% | 406.7% | -41952.8% | -167.5% | -59.0% |
| Current ratio | 2.22 | 0.68 | 0.74 | 5.22 | 10.33 |
Why these scores methodology →
Piotroski F-score: 2/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: n/a
Not applicable (financials/insurer or missing inputs).
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001680048 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.